Literature DB >> 32267829

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy.

Luca Mascaretti1,2, Vincenzo De Angelis3,4, Pierluigi Berti5,6.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32267829      PMCID： PMC7141941          DOI： 10.2450/2020.0071-20

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  7 in total

1.  Blood and disaster--supply and demand.

Authors:  Paul J Schmidt
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

Review 2.  Convalescent plasma: new evidence for an old therapeutic tool?

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

3.  Blood transfusion during the COVID-19 outbreak.

Authors:  Xiaohong Cai; Ming Ren; Fenghua Chen; Liliang Li; Hang Lei; Xuefeng Wang
Journal:  Blood Transfus       Date:  2020-03       Impact factor: 3.443

Review 4.  Coronavirus Disease 2019: Coronaviruses and Blood Safety.

Authors:  Le Chang; Ying Yan; Lunan Wang
Journal:  Transfus Med Rev       Date:  2020-02-21

Review 5.  The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

Authors:  John Mair-Jenkins; Maria Saavedra-Campos; J Kenneth Baillie; Paul Cleary; Fu-Meng Khaw; Wei Shen Lim; Sophia Makki; Kevin D Rooney; Jonathan S Nguyen-Van-Tam; Charles R Beck
Journal:  J Infect Dis       Date:  2014-07-16       Impact factor: 5.226

Review 6.  COVID-19 and Italy: what next?

Authors:  Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Lancet       Date:  2020-03-13       Impact factor: 79.321

7.  Convalescent plasma as a potential therapy for COVID-19.

Authors:  Long Chen; Jing Xiong; Lei Bao; Yuan Shi
Journal:  Lancet Infect Dis       Date:  2020-02-27       Impact factor: 25.071
  7 in total
  10 in total

1.  A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak.

Authors:  Valentino Granero; Paola M Manzini; Anna M Bordiga
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

2.  Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

Authors:  Giuseppe Giannaccare; Marina Buzzi; Piera Versura
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

Review 3.  The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.

Authors:  Gianmarco Lugli; Matteo Maria Ottaviani; Annarita Botta; Guido Ascione; Alessandro Bruschi; Federico Cagnazzo; Lorenzo Zammarchi; Paola Romagnani; Tommaso Portaluri
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

Review 4.  No evidence of SARS-CoV-2 transmission through transfusion of human blood products: A systematic review.

Authors:  William Frank Mawalla; Belinda J Njiro; George M Bwire; Ahlam Nasser; Bruno Sunguya
Journal:  EJHaem       Date:  2021-07-19

5.  Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.

Authors:  Tarek Assi; Bachar Samra; Laurent Dercle; Elie Rassy; Joseph Kattan; Marwan Ghosn; Roch Houot; Samy Ammari
Journal:  Front Oncol       Date:  2020-07-03       Impact factor: 6.244

Review 6.  COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications.

Authors:  Layal Al Mahmasani; Mohammad Hassan Hodroj; Antoine Finianos; Ali Taher
Journal:  Ann Hematol       Date:  2021-02-01       Impact factor: 3.673

Review 7.  COVID-19 insights from transfusion medicine.

Authors:  Willy A Flegel
Journal:  Br J Haematol       Date:  2020-07-28       Impact factor: 8.615

8.  No evidence of SARS-CoV-2 RNA among blood donors: A multicenter study in Hubei, China.

Authors:  Le Chang; Ying Yan; Lei Zhao; Guibin Hu; Lijuan Deng; Dan Su; Dongju Peng; Xinjiao Nie; Song Wang; Yuanyuan Li; Jundao Wang; Zhong Ruan; Shouliang Gao; Huasong Yang; Fei Guo; Lunan Wang
Journal:  Transfusion       Date:  2020-07-14       Impact factor: 3.337

9.  Impact of Covid-19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes.

Authors:  Anna Quaglietta; Antonio Nicolucci; Raffaella Posata; Antonella Frattari; Giustino Parruti; Patrizia Accorsi
Journal:  Transfus Med       Date:  2020-12-02       Impact factor: 2.057

Review 10.  Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency.

Authors:  Philip Kiely; Veronica C Hoad; Clive R Seed; Iain B Gosbell
Journal:  Vox Sang       Date:  2020-09-23       Impact factor: 2.996
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.